Home
>
National Drug Code (NDC)
>
Citalopram
Citalopram - 13107-007-30 - (Citalopram)
Drug Information of Citalopram
| Product NDC: | 13107-007 |
| Proprietary Name: | Citalopram |
| Non Proprietary Name: | Citalopram |
| Active Ingredient(s): | 40 mg/1 & nbsp; Citalopram |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Citalopram
| Product NDC: | 13107-007 |
| Labeler Name: | Aurolife Pharma LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077031 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090101 |
Package Information of Citalopram
| Package NDC: | 13107-007-30 |
| Package Description: | 30 TABLET in 1 BOTTLE (13107-007-30) |
NDC Information of Citalopram
| NDC Code | 13107-007-30 |
| Proprietary Name | Citalopram |
| Package Description | 30 TABLET in 1 BOTTLE (13107-007-30) |
| Product NDC | 13107-007 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Citalopram |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20090101 |
| Marketing Category Name | ANDA |
| Labeler Name | Aurolife Pharma LLC |
| Substance Name | CITALOPRAM HYDROBROMIDE |
| Strength Number | 40 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |
